Group One Trading
ACAD icon

Group One Trading’s Acadia Pharmaceuticals ACAD Stock Holding History

Group One Trading’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67.5K Sell
3,032
-6,281
-67% -$150K ﹤0.01% 5045
2025
Q4 		$249K Buy
+9,313
New +$223K ﹤0.01% 4179
2025
Q2 		– Sell
-78
Closed -$1.45K – 7850
2025
Q1 		$1.3K Sell
78
-5,187
-99% -$94.2K ﹤0.01% 7117
2024
Q4 		$96.6K Sell
5,265
-27,626
-84% -$446K ﹤0.01% 4546
2024
Q3 		$506K Buy
32,891
+716
+2% +$11.9K ﹤0.01% 2853
2024
Q2 		$523K Buy
32,175
+19,307
+150% +$312K ﹤0.01% 2521
2024
Q1 		$238K Buy
+12,868
New +$319K ﹤0.01% 3407
2023
Q4 		– Sell
-173,593
Closed -$4.15M – 7281
2023
Q3 		$3.62M Buy
+173,593
New +$4.71M 0.01% 1155
2022
Q3 		– Sell
-88,059
Closed -$1.43M – 7445
2022
Q2 		$1.24M Buy
+88,059
New +$1.64M ﹤0.01% 2543
2022
Q1 		– Sell
-182,133
Closed -$4.41M – 7943
2021
Q4 		$4.25M Buy
182,133
+174,022
+2,146% +$3.5M ﹤0.01% 1857
2021
Q3 		$135K Sell
8,111
-32,245
-80% -$622K ﹤0.01% 5592
2021
Q2 		$984K Sell
40,356
-47,432
-54% -$1.07M ﹤0.01% 3435
2021
Q1 		$2.27M Buy
87,788
+42,905
+96% +$1.89M ﹤0.01% 2332
2020
Q4 		$2.4M Sell
44,883
-25,596
-36% -$1.27M ﹤0.01% 1897
2020
Q3 		$2.91M Buy
70,479
+31,680
+82% +$1.37M 0.01% 1294
2020
Q2 		$1.88M Sell
38,799
-25,714
-40% -$1.23M 0.01% 1506
2020
Q1 		$2.73M Sell
64,513
-20,238
-24% -$834K 0.02% 848
2019
Q4 		$3.63M Sell
84,751
-102,801
-55% -$4.47M 0.02% 877
2019
Q3 		$6.75M Buy
+187,552
New +$5.69M 0.05% 431
2018
Q4 		– Sell
-50,829
Closed -$987K – 4794
2018
Q3 		$1.05M Buy
50,829
+26,916
+113% +$423K 0.01% 1665
2018
Q2 		$365K Sell
23,913
-58,253
-71% -$1.04M ﹤0.01% 2565
2018
Q1 		$1.85M Sell
82,166
-50,914
-38% -$1.41M 0.02% 1061
2017
Q4 		$4.01M Sell
133,080
-139,795
-51% -$4.47M 0.03% 764
2017
Q3 		$10.3M Sell
272,875
-8,931
-3% -$291K 0.09% 262
2017
Q2 		$7.86M Buy
281,806
+69,010
+32% +$2.06M 0.08% 291
2017
Q1 		$7.32M Buy
212,796
+197,368
+1,279% +$6.97M 0.09% 274
2016
Q4 		$445K Sell
15,428
-106,961
-87% -$2.83M ﹤0.01% 1851
2016
Q3 		$3.89M Buy
122,389
+4,935
+4% +$167K 0.04% 518
2016
Q2 		$3.81M Buy
+117,454
New +$3.93M 0.05% 497
2016
Q1 		– Sell
-33,254
Closed -$1.19M – 4509
2015
Q4 		$1.19M Sell
33,254
-150,688
-82% -$5.31M 0.01% 1201
2015
Q3 		$6.08M Buy
183,942
+41,013
+29% +$1.71M 0.08% 284
2015
Q2 		$5.99M Sell
142,929
-64,070
-31% -$2.48M 0.08% 256
2015
Q1 		$6.75M Sell
206,999
-59,605
-22% -$2.05M 0.11% 179
2014
Q4 		$8.46M Sell
266,604
-136,340
-34% -$3.87M 0.13% 153
2014
Q3 		$9.98M Sell
402,944
-38,944
-9% -$911K 0.15% 114
2014
Q2 		$9.98M Sell
441,888
-127,658
-22% -$2.67M 0.15% 120
2014
Q1 		$13.9M Buy
569,546
+97,942
+21% +$2.48M 0.23% 66
2013
Q4 		$11.8M Buy
471,604
+85,627
+22% +$2.02M 0.18% 81
2013
Q3 		$10.6M Buy
385,977
+63,509
+20% +$1.33M 0.2% 78
2013
Q2 		$5.85M Buy
+322,468
New +$4.44M 0.14% 134

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Group One Trading's ACAD Position: Q1 2026 in Review

Group One Trading reduced its Acadia Pharmaceuticals (ACAD) stake by 67% in Q1 2026, selling an estimated $150K and leaving 3,032 shares worth $67.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5045.

Group One Trading first reported a position in ACAD in Q2 2013 and has held it in 40 quarters since. The position peaked at $13.9M in Q1 2014. 342 funds tracked by Wall St. Rank hold ACAD as of Q1 2026.

  • Group One Trading held 3,032 shares of Acadia Pharmaceuticals worth $67.5K as of Q1 2026.
  • Group One Trading sold 6,281 Acadia Pharmaceuticals shares in Q1 2026, an estimated $150K.
  • Acadia Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5045 holding.
  • Group One Trading first reported a position in Acadia Pharmaceuticals in Q2 2013 and has held it in 40 quarters since.
  • Group One Trading's Acadia Pharmaceuticals position peaked at $13.9M in Q1 2014.
  • 342 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.